Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines

A Bundscherer, C Hafner, T Maisch… - Oncology …, 2008 - spandidos-publications.com
Abstract Inhibitors of cyclooxygenase 2 (COX 2) and the mammalian target of rapamycin
(mTOR) show direct and indirect antitumor effects in a variety of cancers. This study was …

[引用][C] Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines

A BUNDSCHERER, C HAFNER, T MAISCH… - Oncology …, 2008 - pascal-francis.inist.fr
Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant
melanoma cell lines CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[PDF][PDF] Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines

A BUNDSCHERER, C HAFNER… - ONCOLOGY …, 2008 - scholar.archive.org
Inhibitors of cyclooxygenase 2 (COX 2) and the mammalian target of rapamycin (mTOR)
show direct and indirect antitumor effects in a variety of cancers. This study was designed to …

[引用][C] Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines

A Bundscherer - Oncol Rep, 2008 - cir.nii.ac.jp
Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma
cell lines | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines

A Bundscherer, C Hafner, T Maisch… - Oncology …, 2008 - pubmed.ncbi.nlm.nih.gov
Inhibitors of cyclooxygenase 2 (COX 2) and the mammalian target of rapamycin (mTOR)
show direct and indirect antitumor effects in a variety of cancers. This study was designed to …

Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines

A Bundscherer, C Hafner, T Maisch… - Oncology …, 2008 - spandidos-publications.com
Abstract Inhibitors of cyclooxygenase 2 (COX 2) and the mammalian target of rapamycin
(mTOR) show direct and indirect antitumor effects in a variety of cancers. This study was …

Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines.

A Bundscherer, C Hafner, T Maisch, B Becker… - Oncology …, 2008 - europepmc.org
Inhibitors of cyclooxygenase 2 (COX 2) and the mammalian target of rapamycin (mTOR)
show direct and indirect antitumor effects in a variety of cancers. This study was designed to …

[PDF][PDF] Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines

A BUNDSCHERER, C HAFNER… - ONCOLOGY …, 2008 - researchgate.net
Inhibitors of cyclooxygenase 2 (COX 2) and the mammalian target of rapamycin (mTOR)
show direct and indirect antitumor effects in a variety of cancers. This study was designed to …

Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines

A Bundscherer, C Hafner, T Maisch, B Becker… - Oncology …, 2008 - ingentaconnect.com
Inhibitors of cyclooxygenase 2 (COX 2) and the mammalian target of rapamycin (mTOR)
show direct and indirect antitumor effects in a variety of cancers. This study was designed to …

[引用][C] Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines

A BUNDSCHERER, C HAFNER, T MAISCH… - Oncology reports, 2008 - Spandidos